Kenji Ozawa

Title: Kenji Ozawa: Innovator in Cephalosporin Antibiotics

Introduction

Kenji Ozawa is a notable inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin antibiotics. His innovative work has led to the creation of novel compounds that are essential in the synthesis of these important medications.

Latest Patents

Kenji Ozawa holds a patent for "3-Methylene cephalosporanic acid derivatives and process for preparation." This patent describes novel substituted hydrazide derivatives of 7-(substituted)amino-3-methylene-cepham-4-carboxylic acids. The compounds are characterized by specific structural formulas, where R1 represents alkyl containing at least three carbon atoms, cycloalkyl, or optionally substituted aryl. The patent outlines a process for preparing these compounds in high yields, making them useful intermediates for synthesizing cephalosporin antibiotics.

Career Highlights

Kenji Ozawa is associated with Teijin Limited, a company known for its advancements in various fields, including pharmaceuticals. His work has been instrumental in enhancing the efficiency and effectiveness of antibiotic production. With a focus on innovative solutions, he has contributed to the development of new therapeutic options for patients.

Collaborations

Kenji has collaborated with notable colleagues such as Sachio Ishimoto and Hisao Yamaguchi. Their combined expertise has fostered advancements in the pharmaceutical industry, particularly in antibiotic research and development.

Conclusion

Kenji Ozawa's contributions to the field of cephalosporin antibiotics highlight his innovative spirit and dedication to improving healthcare. His patent work and collaborations reflect a commitment to advancing pharmaceutical science.